Search for: "State v. Leisure" Results 321 - 340 of 419
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Nov 2010, 2:16 am by Kelly
Kappos (IP Spotlight) (Patent Docs) Sham patent reexamination action not available in State Court says CAFC: Lockwood v. [read post]
16 Nov 2010, 1:55 pm
 It's Sporte Leisure Pty Ltd v Paul's International Pty Ltd (No 3) [2010] FCA 1162, of 20 October 2010. [read post]
4 Nov 2010, 2:08 am by war
Sporte Leisure Pty Ltd v Paul’s International Pty Ltd (No 3) [2010] FCA 1162 [read post]
10 Oct 2010, 9:47 pm by Simon Gibbs
In Crane v Canons Leisure Centre [2007] EWCA Civ 1352 the Court was concerned with whether work undertaken by independent costs draftsmen (referred to in the judgment as costs consultants and apparently not members of the ALCD) could be treated as part of the instructing solicitors’ profit costs such as to attract a success fee. [read post]
22 Sep 2010, 1:11 pm
"International environmental norms reflect not how states regularly behave, but how states speak to each other. [read post]
14 Sep 2010, 9:09 am by Rebecca Tushnet
And other states have other tests. [read post]
31 Aug 2010, 8:38 pm by Pulat Yunusov
After he was released on parole, John started a “successful commercial art and design studio in Toronto” (Hawley v. [read post]
2 Aug 2010, 5:00 am by Nissenbaum Law Group
See In re Mullarkey, 536 F.3d at 230 (describing the doctrine as applicable where a plaintiff alleges that the mortgagee breached the parties' underlying agreement) (discussing Leisure Technology-Northeast, Inc. v. [read post]
28 Jul 2010, 5:00 am by Nissenbaum Law Group
See In re Mullarkey, 536 F.3d at 230 (describing the doctrine as applicable where a plaintiff alleges that the mortgagee breached the parties' underlying agreement) (discussing Leisure Technology-Northeast, Inc. v. [read post]
20 Jul 2010, 6:26 pm by Steve Bainbridge
I was reminded of all this by Francis Pileggi's post on a recent Delaware case, Hampshire Group, Limited v. [read post]
28 Jun 2010, 8:00 am by J Robert Brown Jr.
The court’s decision dramatically expands the number of investor suits against pharmaceutical companies that state a claim and substantially increases the pressure on companies to settle meritless claims. [read post]